Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.61 |
| ▸ | AGXT | P21549 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 5/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1151673 | 0.81 | IDO1 (0.61) | IDO1AGXTALDH1A1SMN1; SMN2TP53 | |
| SCHEMBL31270 | 0.80 | IDO1 (0.67) | IDO1AGXTALDH1A1SMN1; SMN2TP53 | |
| SCHEMBL34413 | 0.80 | IDO1 (0.67) | IDO1AGXTALDH1A1SMN1; SMN2TP53 | |
| SCHEMBL1475481 | 0.78 | IDO1 (0.64) | IDO1AGXTALDH1A1SMN1; SMN2TP53 | |
| SCHEMBL20000873 | 0.78 | APP (0.80) | IDO1AGXTALDH1A1SMN1; SMN2APP | |
| Potassium SCHEMBL1477050 | 0.78 | IDO1 (0.64) | IDO1AGXTALDH1A1SMN1; SMN2TP53 | |
| SCHEMBL5633601 | 0.77 | NQO1 (0.61) | ALDH1A1SMN1; SMN2TSHRAPPCA12 | |
| SCHEMBL2089652 | 0.77 | IDO1 (0.57) | IDO1AGXTALDH1A1SMN1; SMN2TP53 | |
| SCHEMBL23790910 | 0.76 | IDO1 (0.61) | IDO1AGXTALDH1A1SMN1; SMN2TP53 | |
| SCHEMBL21588833 | 0.76 | IDO1 (0.61) | IDO1AGXTALDH1A1SMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4066 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024093947-A1 | PRODRUG FOR DELIVERING SIRNA INTO CELL | 大睿生物医药科技(上海)有限公司 | 2024-05-10 | — | — | WO | claimed |
| WO-2024093907-A1 | LIGAND FOR DELIVERING SIRNA TO EYE AND CENTRAL NERVOUS SYSTEM | 大睿生物医药科技(上海)有限公司 | 2024-05-10 | — | — | WO | claimed |
| EP-2991655-B1 | COMPOSITIONS AND METHODS FOR ALTERING SECOND MESSENGER SIGNALING | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-04-10 | — | — | EP | claimed |
| CN-117659032-A | Intermediate of ecteinascidin derivative and synthetic method thereof | 南通诺泰生物医药技术有限公司 | 2024-03-08 | — | — | CN | claimed |
| US-20230374060-A1 | NOVEL METHOD FOR PREPARING INOTODIOL | DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION (KR) | 2023-11-23 | — | — | US | claimed |
| EP-3606528-B1 | TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF | BROAD INST INC (US) | 2023-10-18 | — | — | EP | claimed |
| CN-110997645-B | Preparation method of ozagrel | 埃吉斯制药公司 | 2023-10-10 | — | — | CN | claimed |
| EP-3630738-B1 | PROCESS FOR THE PRODUCTION OF OZANIMOD | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 2023-07-19 | — | — | EP | claimed |
| EP-3634970-B1 | NOVEL PROCESS FOR PREPARATION OF EMPAGLIFLOZIN OR ITS CO-CRYSTALS, SOLVATES AND THEIR POLYMORPHS THEREOF | LAURUS LABS LTD (IN) | 2023-07-19 | — | — | EP | claimed |
| US-20230057246-A1 | NOVEL PROCESSES FOR PREPARATION OF TEZACAFTOR | LAURUS LABS LIMITED (IN) | 2023-02-23 | — | — | US | claimed |
| US-5705636-A | Cyclohexene derivatives | GLAXO WELLCOME S.P.A. (IT) | 1998-01-06 | — | — | US | claimed |
| WO-1997027181-A1 | HETEROCYCLO-SUBSTITUTED IMIDAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-07-31 | — | — | WO | claimed |
| EP-0772600-A1 | 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-05-14 | — | — | EP | claimed |
| US-5621099-A | CARDIOVASCULAR DISORDERS | SUNTORY LIMITED (JP) | 1997-04-15 | — | — | US | claimed |
| US-5616601-A | 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation | GD SEARLE & CO (US) | 1997-04-01 | — | — | US | claimed |
| US-5583235-A | ALKENYLATION, CYCLIZATION | SHAMAN PHARMACEUTICALS, INC. (US) | 1996-12-10 | — | — | US | claimed |
| EP-0711773-A1 | HYMENIALDISINE AND DERIVATIVE THEREOF, PROCESS FOR PRODUCING INTERMEDIATE FOR SYNTHESIZING THE SAME, AND SAID INTERMEDIATE | SUNTORY LIMITED (JP) | 1996-05-15 | — | — | EP | claimed |
| WO-1996003388-A1 | 1,2-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-02-08 | — | — | WO | claimed |
| WO-1995029923-A1 | PROCESS FOR THE PREPARATION OF MONO- AND BIS(PHOSPHOCHOLINE) DERIVATIVES WHICH HAVE ANTIFUNGAL ACTIVITY | SHAMAN PHARMACEUTICALS, INC. (US) | 1995-11-09 | — | — | WO | claimed |
| US-5278332-A | Derivatives of cyclohexane | PERSTORP AB (SE) | 1994-01-11 | — | — | US | claimed |